Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

Jeffrey Sanders, MD

Dr Sanders is a resident at the University of Oklahoma School of Community Medicine in Tulsa.

Articles by Jeffrey Sanders, MD

Insights From the 2022 AAPL Annual Meeting

ByBritta K. Ostermeyer, MD, MBA,Susan Hatters Friedman, MD, MSt, DFAPA,Joshua Friedman, MD, PhD,Jason Beaman, DO, MS, MPH,Katie Kruse, MD,Jeffrey Sanders, MD,Tessa Manning, MD,Elie G. Aoun, MD,Barry Wall, MD,Bethany Hughes, MD,Ren Belcher, MD,Charles Dike, FRCPsych, MBChB, MPH

January 19th 2023

The American Academy of Psychiatry and the Law hosted its first in-person meeting in October 2022. Check out these highlights.

Latest Updated Articles

Trending on Psychiatric Times

ADHD Found Connected to Substance Use Disorder, With Sex Prevalence Differences

Sleep as Connective Tissue: Quantifying Team Dynamics in Elite Sports

Lithium-Loaded Gold Nanoparticle Nasal Spray to Treat Neuropsychiatric Diseases

A Moral Injury Update: The PNHP Study and an Imminent Step Toward Peace in the Mideast

Suicide: Can Emergency Departments Assist in its Prevention?

© 2025 MJH Life Sciences^®

All rights reserved.